Cargando…

In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia

PURPOSE: To better guide clinical use, we determined the in vitro antimicrobial activity of the new drug eravacycline and other tetracycline derivatives against levofloxacin (LVFX)-non-susceptible and/or trimethoprim-sulfamethoxazole (TMP-SMZ)-resistant Stenotrophomonas maltophilia and evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jie, Zhang, Guangcun, Zhao, Qiang, Wang, Lifeng, Yang, Jiyong, Cui, Junchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497097/ https://www.ncbi.nlm.nih.gov/pubmed/37705512 http://dx.doi.org/10.2147/IDR.S425061

Ejemplares similares

Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
por: Al-Jasser, Asma Marzouq
Publicado: (2006)

Osteomyelitis due to Stenotrophomonas maltophilia treated with trimethoprim-sulfamethoxazole monotherapy
por: Osakwe, Nonso
Publicado: (2023)

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
por: Biagi, M., et al.
Publicado: (2020)

The sul1 Gene in Stenotrophomonas maltophilia With High-Level Resistance to Trimethoprim/Sulfamethoxazole
por: Chung, Hae-Sun, et al.
Publicado: (2015)

1491. Standard- vs. High-dose Trimethoprim-Sulfamethoxazole for Stenotrophomonas maltophilia pneumonia
por: Hall, Brenton C, et al.
Publicado: (2020)

Global Emergence of Trimethoprim/Sulfamethoxazole Resistance in Stenotrophomonas maltophilia Mediated by Acquisition of sul Genes
por: Toleman, Mark A., et al.
Publicado: (2007)

Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China
por: Hu, Li-Fen, et al.
Publicado: (2016)

Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments
por: Wei, Chuanqi, et al.
Publicado: (2016)

Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
por: Sarzynski, Sadia H, et al.
Publicado: (2022)

Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
Publicado: (2023)

Role of sul2 Gene Linked to Transposase in Resistance to Trimethoprim/Sulfamethoxazole Among Stenotrophomonas maltophilia Isolates
por: Hu, Li-Fen, et al.
Publicado: (2016)

Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia: is resistance to sulfamethoxazole/trimethoprim a problem?
por: Mendes, Elisa Teixeira, et al.
Publicado: (2020)

A 20-year trend of prevalence and susceptibility to trimethoprim/sulfamethoxazole of Stenotrophomonas maltophilia in a single secondary care hospital in Korea
por: Song, Je Eun, et al.
Publicado: (2023)

2419. Standard vs. Alternative Therapy for Stenotrophomonas maltophilia Infections: Focus on Trimethoprim–Sulfamethoxazole, Minocycline, and Moxifloxacin Monotherapy
por: Badwal, Jasmin, et al.
Publicado: (2018)

Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim–sulfamethoxazole
por: McCutcheon, Jaclyn G., et al.
Publicado: (2022)

In Vitro Antibacterial and Antibiofilm Activities of Chlorogenic Acid against Clinical Isolates of Stenotrophomonas maltophilia including the Trimethoprim/Sulfamethoxazole Resistant Strain
por: Karunanidhi, Arunkumar, et al.
Publicado: (2013)

Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia
por: Baek, Ji Hyeon, et al.
Publicado: (2014)

1235. Roles of Tetracyclines for Treatment of Stenotrophomonas maltophilia Pneumonia
por: Alhayani, Taha, et al.
Publicado: (2021)

Renal Transplant Recipient with Concurrent COVID-19 and Stenotrophomonas maltophilia Pneumonia Treated with Trimethoprim/Sulfamethoxazole Leading to Acute Kidney Injury: A Therapeutic Dilemma
por: Mohamed, Mohamed A., et al.
Publicado: (2020)

Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms
por: Sun, Erlin, et al.
Publicado: (2016)

Tetracycline-modifying enzyme SmTetX from Stenotrophomonas maltophilia
por: Malý, Martin, et al.
Publicado: (2023)

Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020)

Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values
por: Vialichka, Alesia, et al.
Publicado: (2022)

The Contribution of Efflux Systems to Levofloxacin Resistance in Stenotrophomonas maltophilia Clinical Strains Isolated in Warsaw, Poland
por: Zając, Olga M., et al.
Publicado: (2022)

Antimicrobial Susceptibility, Minimum Inhibitory Concentrations, and Clinical Profiles of Stenotrophomonas maltophilia Endophthalmitis
por: Ho, Ming-Chih, et al.
Publicado: (2021)

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014)

Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole
por: Su, Pei-Yi, et al.
Publicado: (2023)

Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates
por: Chung, Hae-Sun, et al.
Publicado: (2013)

Risk Factors for Mortality in Hospitalized Patients with Stenotrophomonas maltophilia Bacteremia
por: Jian, Jiyong, et al.
Publicado: (2022)

Stenotrophomonas maltophilia in Salad
por: Qureshi, Andleeb, et al.
Publicado: (2005)

Stenotrophomonas maltophilia pericarditis
por: Avşar, Cansu Bulut, et al.
Publicado: (2017)

The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness
por: Tatman-Otkun, Müşerref, et al.
Publicado: (2005)

Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from a Korean Tertiary Care Hospital
por: Chung, Hae-Sun, et al.
Publicado: (2012)

Evaluation of Veterinary-Specific Interpretive Criteria for Susceptibility Testing of Streptococcus equi Subspecies with Trimethoprim-Sulfamethoxazole and Trimethoprim-Sulfadiazine
por: Sadaka, Carmen, et al.
Publicado: (2016)

Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen Stenotrophomonas maltophilia
por: Paprocka, Paulina, et al.
Publicado: (2022)

Myocarditis after Trimethoprim/Sulfamethoxazole Treatment for Ehrlichiosis
por: Nayak, Seema U., et al.
Publicado: (2013)

Life-Threatening Thrombocytopenia Secondary to Trimethoprim/Sulfamethoxazole
por: Gaudel, Pramod, et al.
Publicado: (2017)

Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline
por: Long, Clara Y, et al.
Publicado: (2021)

Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome
por: Samonis, George, et al.
Publicado: (2012)

Stenotrophomonas maltophilia PhoP, a Two-Component Response Regulator, Involved in Antimicrobial Susceptibilities
por: Liu, Ming-Che, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bhtet805dmugphggsf0jlegmvb